Sorafenib based drugs: price, availability and description

Sorafenib is an anti-cancer drug, a multikinase inhibitor. It slows down the growth of cancer cells and cuts off the blood supply to the tumor. Sorafenib is indicated for the treatment of hepatocellular carcinoma (primary liver cancer), advanced renal cell carcinoma (kidney cancer), and differentiated thyroid carcinoma that is resistant to radioactive iodine treatment.